Navidea Biopharmaceuticals Announces Addition to Major Indexes on Tel Aviv Stock Exchange Sep 28, 2015
Navidea Biopharmaceuticals to Present at the Ladenburg Thalmann 2015 Healthcare Conference Sep 17, 2015
Navidea Awarded $1.8M Fast Track NIH SBIR Grant for Evaluation of a Manocept™ Agent in Kaposi’s Sarcoma Sep 3, 2015
Navidea Biopharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference Sep 2, 2015
Navidea Biopharmaceuticals to Register Shares for Dual Listing on Tel-Aviv Stock Exchange Aug 24, 2015
Navidea Reports Publication of Lymphoseek® Comparative Results in Injection Site Pain Study in Breast Cancer Aug 20, 2015
